
Sign up to save your podcasts
Or


Dr. Nathaniel Huebsch is an Assistant Professor of Biomedical Engineering at Washington University in St. Louis. His lab focuses on understanding how mechanical cues originating at cell-cell and cell-extracellular matrix contacts influence signaling and fate. They are especially interested in how those cues affect heart development and disease. He talks about cardiac models and cardiomyocyte maturity.
Modeling Early Development – Peri-gastruloids model human post-implantation development into early organogenesis.
Fatty Acid Synthesis in Endoderm Differentiation – Researchers identified a fatty acid synthesis/oxidation shift during early differentiation.
Editing HSCs In Vivo – Scientists designed a strategy to reprogram bone marrow stem cells directly within the body without the need for donor cells or the use of potentially toxic conditioning regimens.
T Cell Therapy for Solid Tumors – Gavo-cel is an engineered T cell therapy tested in patients with mesothelin-expressing solid tumors.
Never miss updates about new episodes.
By The Stem Cell Podcast4.7
101101 ratings
Dr. Nathaniel Huebsch is an Assistant Professor of Biomedical Engineering at Washington University in St. Louis. His lab focuses on understanding how mechanical cues originating at cell-cell and cell-extracellular matrix contacts influence signaling and fate. They are especially interested in how those cues affect heart development and disease. He talks about cardiac models and cardiomyocyte maturity.
Modeling Early Development – Peri-gastruloids model human post-implantation development into early organogenesis.
Fatty Acid Synthesis in Endoderm Differentiation – Researchers identified a fatty acid synthesis/oxidation shift during early differentiation.
Editing HSCs In Vivo – Scientists designed a strategy to reprogram bone marrow stem cells directly within the body without the need for donor cells or the use of potentially toxic conditioning regimens.
T Cell Therapy for Solid Tumors – Gavo-cel is an engineered T cell therapy tested in patients with mesothelin-expressing solid tumors.
Never miss updates about new episodes.

90,985 Listeners

32,087 Listeners

4,133 Listeners

26,261 Listeners

767 Listeners

823 Listeners

6,453 Listeners

112,144 Listeners

56,553 Listeners

8,027 Listeners

6,556 Listeners

6,398 Listeners

16,139 Listeners

2,305 Listeners

1,635 Listeners